Company / Cash per Share
Apellis Pharmaceuticals, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.74
FY2025
5-year range
$3.17 / $8.41
FY2021-FY2025
Trend
+8.9%
vs FY2024
Sector context
#53 of 205
Health Care
What the data says
At $3.74, Apellis Pharmaceuticals, Inc.'s cash per share ranks #53 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $2.95 in FY2016 to $12.66 in FY2017.
Based on SEC 10-K filings.
3.74 in FY2025 with a 5-year CAGR of -15.8%.
Improved from $3.17 to $3.74 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -12.9%
- 5-Year CAGR
- -15.8%
- 10-Year CAGR
- -
Sector benchmark
#53 of 205 in Health CareTop 26% of 205This company $3.74 Sector average $72.93
▼
-94.9% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 8.9% year-over-year.
- Ranks #53 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.74 | +8.9% |
| FY2024 | $3.44 | +8.5% |
| FY2023 | $3.17 | -44.0% |
| FY2022 | $5.66 | -32.7% |
| FY2021 | $8.41 | -5.0% |
| FY2020 | $8.85 | +56.4% |
| FY2019 | $5.66 | +74.6% |
| FY2018 | $3.24 | -74.4% |
| FY2017 | $12.66 | +329.2% |
| FY2016 | $2.95 | -52.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026